Keywords: Gilead Sciences, Complera, HIV, USA, FDA, Johnson & Johnson, Tibotech, Genentech, Roche, Production facilities

Gilead gains US approval for Complera, resolves manufacturing problem and buys Genentech facility

Article | 11 August 2011

Print This

In what were a couple of busy news days for US biotech firm Gilead Sciences (Nasdaq: GILD), the company received ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in